Skip to main content
. 2022 Aug 19;12:951026. doi: 10.3389/fonc.2022.951026

Table 3.

Responder rates in anthracycline-based regimen vs all other therapies.

Therapy Responders Non-Responders p-Value (chi-square test)
Anthracycline-based regimen 8 (53%) 7 (47%) p < 0.001
All other therapies 35 (100%) 0